by Jason Heaviland | Oct 1, 2026
Why Has Genomics Not Solved Most Chronic Diseases? Why hasn’t genomics solved most chronic diseases? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains why genomics has provided valuable insights into health and disease, but cannot capture every factor...
by Jason Heaviland | Sep 29, 2026
How Is Multi-Omics Changing Chronic Disease Diagnosis? How is multi-omics changing the way researchers define and diagnose chronic disease? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains how combining molecular data can provide greater resolution...
by Jason Heaviland | Sep 28, 2026
What Is the Biggest Challenge in Integrating Multi-Omics Data? How can researchers make complex multi-omics datasets work together? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains the challenges of integrating genomics, proteomics, metabolomics, and...
by Jason Heaviland | Jun 15, 2026
This data report presents the complete Cell Surface Multi-Omics analysis of KRAS-knockdown and wild-type HCT-116 cells, including cell surface proteomics, membrane lipidomics, differential expression analysis and integrated protein–lipid interpretation from matched...
by Jason Heaviland | Jun 15, 2026
KRAS Knockdown Remodels Surface Proteins and Lipids Cell Surface Multi-Omics combines cell surface proteomics and membrane lipidomics from matched membrane fractions to characterize the protein and lipid architecture of the cell surface. In KRAS-knockdown HCT-116...
